CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, was ...

The global preclinical medical device testing services market is on the verge of substantial expansion, projected to soar from USD 2.8 billion in 2022 to an impressive USD 6.63 billion by 2032. This ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

What Are DNA Companies Nowadays DNA companies have made huge changes to the fields of genetic research and personal health These companies not only find the secrets hidden in genetic codes but they al ...

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

Genetic testing can help identify inherited gene mutations ... Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.

a leading health technology company, that allows physicians to order Myriad Genetics' MyRisk Hereditary Cancer Test and view ...

Aliso Viejo-based Ambrey Genetics Corp., Orange County’s third-largest medical diagnostics and testing company, has entered ...

ACIBADEM LabMed Laboratories is committed to delivering accurate and reliable medical testing services through advanced ...